مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

130
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

208
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Efficacy of Oral Alendronate Versus Zoledronic Acid on Postmenopausal Osteoporosis

Pages

  0-0

Abstract

 Background: Osteoporosis is a common condition among Postmenopausal women, and one of the main medications for treatment is bisphosphonate compounds. Objectives: The aim of this study was to investigate and compare the efficacy of the oral form (Alendronate) with injectable form (Zoledronic Acid) of bisphosphonate compounds. Methods: This retrospective cohort study was carried out over three years (2010 to 2012) on patients referred to Physical Medicine Clinic of Tehran, Imam Reza Hospital, and two private rheumatology clinics in the cities of Gorgan and Shiraz, Iran. According to inclusion and exclusion criteria, 33 Postmenopausal women were studied in each of the Alendronate and Zoledronic Acid groups. Results: Mean age and T-score of femur and lumbar spine before treatment showed no significant difference between the two groups (P = 0. 223, 0. 321 and 0. 953, respectively). After a year of treatment, the T-score had improved and this improvement was statistically significant in both groups; however this improvement was higher in Zoledronic Acid group (P = 0. 019 for femur and P = 0. 011 for spine). Conclusions: The injectable form of bisphosphonates (Zoledronic Acid) compared to oral form (Alendronate) has more effect on improving Osteoporosis and T-score of Postmenopausal women.

Cites

  • No record.
  • References

    Cite

    APA: Copy

    NAJAFI, SHARIF, Rezasoltani, Zahra, AZMA, KAMRAN, Nayeb Abbas, Saman, AGHAEI, MEHRDAD, & SANATI, EHSAN. (2019). Efficacy of Oral Alendronate Versus Zoledronic Acid on Postmenopausal Osteoporosis. ANNALS OF MILITARY AND HEALTH SCIENCES RESEARCH, 17(2), 0-0. SID. https://sid.ir/paper/756503/en

    Vancouver: Copy

    NAJAFI SHARIF, Rezasoltani Zahra, AZMA KAMRAN, Nayeb Abbas Saman, AGHAEI MEHRDAD, SANATI EHSAN. Efficacy of Oral Alendronate Versus Zoledronic Acid on Postmenopausal Osteoporosis. ANNALS OF MILITARY AND HEALTH SCIENCES RESEARCH[Internet]. 2019;17(2):0-0. Available from: https://sid.ir/paper/756503/en

    IEEE: Copy

    SHARIF NAJAFI, Zahra Rezasoltani, KAMRAN AZMA, Saman Nayeb Abbas, MEHRDAD AGHAEI, and EHSAN SANATI, “Efficacy of Oral Alendronate Versus Zoledronic Acid on Postmenopausal Osteoporosis,” ANNALS OF MILITARY AND HEALTH SCIENCES RESEARCH, vol. 17, no. 2, pp. 0–0, 2019, [Online]. Available: https://sid.ir/paper/756503/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button